KRAS and colorectal carcinoma: Among the genetic mutations, the Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) gene mutated in 40% and the BRAF gene mutated in 10% of CRC patients are useful predictive markers for metastatic disease [2,18,19].